Literature DB >> 29133970

Laser and Platelet-Rich Plasma to treat Medication-Related Osteonecrosis of the Jaws (MRONJ): a case report.

Carlo Fornaini1,2, Luigi Cella1, Aldo Oppici1, Anna Parlatore3, Fabio Clini1, Matteo Fontana1, Giuseppe Lagori1, Elisabetta Merigo1,2.   

Abstract

AIMS: The appropriate management of Medication-Related OsteoNecrosis of the Jaw (MRONJ) is still a challenge for dentists and oral surgeons and in these last years high-technology instruments have been proposed at the different steps of interventions, also combined with promoters of tissue repair.The aim of this report is to show the advantages of a combined approach (laser and PRP) for the treatment of MRONJ.
METHODS: It is described the case of a patient positive for MRONJ observed at the Odontostomatology and Maxillo-Facial Surgery Unit of the Hospital of Piacenza where surgical approach was performed by using different devices: Er:YAG laser (2940 nm) to remove and vaporize necrotic hard tissue until bleeding bone; Platelet-Rich Plasma (PRP) to stimulate hard and soft tissue healing; diode laser (808 nm) to biostimulate the surgical site.
RESULTS: At the time of suture removal, wound closure was observed and the complete healing of the MRONJ site was observed for the 2 years follow up.
CONCLUSION: This case may suggest that this kind of combined approach during all the steps of MRONJ treatment allows to perform a faster and less invasive surgery with a more comfortable postoperative healing process and it represents an innovative approach in this severe adverse event.

Entities:  

Keywords:  Er:YAG laser; Laser; Medication-Related Osteonecrosis of the Jaws; Photobiomodulation; Platelet-Rich Plasma

Year:  2017        PMID: 29133970      PMCID: PMC5675913          DOI: 10.5978/islsm.17-CR-04

Source DB:  PubMed          Journal:  Laser Ther        ISSN: 0898-5901


  12 in total

1.  Efficacy of platelet-rich plasma in alveolar bone grafting.

Authors:  Tomoki Oyama; Soh Nishimoto; Tomoe Tsugawa; Fumiaki Shimizu
Journal:  J Oral Maxillofac Surg       Date:  2004-05       Impact factor: 1.895

Review 2.  Bisphosphonates-related osteonecrosis of the jaws: a concise review of the literature and a report of a single-centre experience with 151 patients.

Authors:  Paolo Vescovi; Elisabetta Merigo; Marco Meleti; Maddalena Manfredi; Rebecca Guidotti; Samir Nammour
Journal:  J Oral Pathol Med       Date:  2011-09-30       Impact factor: 4.253

3.  Treatment of avascular osteonecrosis of the mandible in cancer patients with a history of bisphosphonate therapy by combining bone resection and autologous platelet-rich plasma: Report of 3 cases.

Authors:  Marcos Martins Curi; Giuliano Saraceni Issa Cossolin; Daniel Henrique Koga; Sérgio Rocha Araújo; Olavo Feher; Marcelo Oliveira dos Santos; Cristina Zardetto
Journal:  J Oral Maxillofac Surg       Date:  2007-02       Impact factor: 1.895

4.  Platelet-rich plasma: Growth factor enhancement for bone grafts.

Authors:  R E Marx; E R Carlson; R M Eichstaedt; S R Schimmele; J E Strauss; K R Georgeff
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  1998-06

5.  Low-level Er:YAG laser irradiation enhances osteoblast proliferation through activation of MAPK/ERK.

Authors:  Verica Aleksic; Akira Aoki; Kengo Iwasaki; Aristeo Atsushi Takasaki; Chen-Ying Wang; Yoshimitsu Abiko; Isao Ishikawa; Yuichi Izumi
Journal:  Lasers Med Sci       Date:  2010-02-26       Impact factor: 3.161

6.  Histological and TEM examination of early stages of bone healing after Er:YAG laser irradiation.

Authors:  Amir Pourzarandian; Hisashi Watanabe; Akira Aoki; Shizuko Ichinose; Katia M Sasaki; Hiroshi Nitta; Isao Ishikawa
Journal:  Photomed Laser Surg       Date:  2004-08       Impact factor: 2.796

7.  Nd:YAG laser biostimulation in the treatment of bisphosphonate-associated osteonecrosis of the jaw: clinical experience in 28 cases.

Authors:  Paolo Vescovi; Elisabetta Merigo; Maddalena Manfredi; Marco Meleti; Carlo Fornaini; Mauro Bonanini; Jean Paul Rocca; Samir Nammour
Journal:  Photomed Laser Surg       Date:  2008-02       Impact factor: 2.796

8.  American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update.

Authors:  Salvatore L Ruggiero; Thomas B Dodson; John Fantasia; Reginald Goodday; Tara Aghaloo; Bhoomi Mehrotra; Felice O'Ryan
Journal:  J Oral Maxillofac Surg       Date:  2014-05-05       Impact factor: 2.136

9.  Conservative surgical management of stage I bisphosphonate-related osteonecrosis of the jaw.

Authors:  Paolo Vescovi; Elisabetta Merigo; Marco Meleti; Maddalena Manfredi; Carlo Fornaini; Samir Nammour; Giovanni Mergoni; Amin Sarraj; Jose V Bagan
Journal:  Int J Dent       Date:  2014-02-06

10.  New dimensional staging of bisphosphonate-related osteonecrosis of the jaw allowing a guided surgical treatment protocol: long-term follow-up of 266 lesions in neoplastic and osteoporotic patients from the university of bari.

Authors:  Simonetta Franco; Simona Miccoli; Luisa Limongelli; Angela Tempesta; Giorgio Favia; Eugenio Maiorano; Gianfranco Favia
Journal:  Int J Dent       Date:  2014-06-05
View more
  3 in total

1.  Combined Approach to Treat Medication-Related Osteonecrosis of the Jaws.

Authors:  Elisabetta Merigo; Luigi Cella; Aldo Oppici; Maria Cristina Arbasi; Fabio Clini; Matteo Fontana; Carlo Fornaini
Journal:  J Lasers Med Sci       Date:  2018-03-20

2.  Conservative Surgical Treatment of Bisphosphonate-Related Osteonecrosis of the Jaw with Er,Cr:YSGG Laser and Platelet-Rich Plasma: A Longitudinal Study.

Authors:  Rodolfo Mauceri; Vera Panzarella; Laura Maniscalco; Alberto Bedogni; Maria Ester Licata; Antonino Albanese; Francesca Toia; Enzo Maria Giuseppe Cumbo; Giuseppina Mazzola; Olga Di Fede; Giuseppina Campisi
Journal:  Biomed Res Int       Date:  2018-08-19       Impact factor: 3.411

3.  Platelet-Rich Plasma (PRP) Rinses for the Treatment of Non-Responding Oral Lichen Planus: A Case Report.

Authors:  Elisabetta Merigo; Aldo Oppici; Anna Parlatore; Luigi Cella; Fabio Clini; Matteo Fontana; Carlo Fornaini
Journal:  Biomedicines       Date:  2018-02-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.